Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Haemonetics (HAE) over the last 17 years, with Q4 2025 value amounting to -$29.5 million.

  • Haemonetics' Cash from Investing Activities fell 6962.75% to -$29.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$74.9 million, marking a year-over-year increase of 6119.3%. This contributed to the annual value of -$161.9 million for FY2025, which is 4978.27% up from last year.
  • Per Haemonetics' latest filing, its Cash from Investing Activities stood at -$29.5 million for Q4 2025, which was down 6962.75% from -$30.5 million recorded in Q3 2025.
  • In the past 5 years, Haemonetics' Cash from Investing Activities ranged from a high of $18.0 million in Q1 2025 and a low of -$429.1 million during Q2 2021
  • Its 5-year average for Cash from Investing Activities is -$61.8 million, with a median of -$27.3 million in 2023.
  • Per our database at Business Quant, Haemonetics' Cash from Investing Activities tumbled by 85070.34% in 2021 and then soared by 23817.4% in 2025.
  • Over the past 5 years, Haemonetics' Cash from Investing Activities (Quarter) stood at -$20.5 million in 2021, then crashed by 77.88% to -$36.5 million in 2022, then tumbled by 636.81% to -$268.9 million in 2023, then soared by 93.54% to -$17.4 million in 2024, then tumbled by 69.63% to -$29.5 million in 2025.
  • Its Cash from Investing Activities was -$29.5 million in Q4 2025, compared to -$30.5 million in Q3 2025 and -$33.0 million in Q2 2025.